KIRK PAOLINELLI: Open Payments
NPI 1235637240 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $367 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 5 | $87 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Corium, LLC | 7 | $47 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Dyanavel XR, Qelbree, Azstarys, Auvelity, VRAYLAR, Jornay PM, AUSTEDO XR, REXULTI.
Industry payments across ID — which companies pay providers there.
